RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Raw

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net income-45-54-30-22-58-66-50-127101494155341542576
Depreciation and amortization4778111516294967102156186218
Share-based compensation1418255083111106102103119113127151170
Paid-in-Kind Interest---------7489688
Deferred income taxes--------0-277-5-22-55-44
Other non-cash income and expenses--------5-2-14-44-358447
Accounts receivable, net6771632273293601427620026035
Inventory0-1271910-02649115112-49253-12
Prepaid and other assets-111034737221132-196
Operating lease right-of-use assets and liabilities, net--------210657
Accounts payable and accrued liabilities10281821215610919558295467212
Accrued payroll and related expenses1262891524162610937-60
Deferred revenue and other liabilities-01-002531-019911-3-8
Net cash provided by operating activities-30-33224495692123315476443670749990
Purchase of marketable securities10366161445391724532,0303,0582,4732,2663,2002,576
Proceeds from sale and maturity of marketable securities-10445132839933921,1962,2512,6662,1282,9472,824
Purchases of property and equipment81081633566667180199389365237359
Acquisitions, net of cash acquired----1--11--304--
Purchases of non-marketable equity securities-------11----81
Other investing activities---------11-10141816
Net cash used in investing activities-462821-17-51-56-144-140-1,015-1,018-216-521-507-207
Proceeds from Issuance of Common Stock754122419101011121520232728
Purchases of treasury stock-------100---558689750
Proceeds from Convertible Debt------389837-1,189--1,231-
Purchases of capped call transactions------------101-
Payments for conversions of senior convertible notes------------787-
Other financing activities--------2-1-9-10-172-13
Net cash used in financing activities741012221783997101191210-552-319-735
Effect of exchange rate changes on cash, cash equivalents and restricted cash-------2-12-1-62-7
Increase (decrease) in cash, cash equivalents and restricted cash-------696-691372235-410-7640
Debt Conversion, Converted Instrument, Amount---------1,351158361,502-
Shares received under note hedge upon conversion of 2023 Notes----------131341,490-
Noncash or Part Noncash Acquisition, Fixed Assets Acquired------611143545265375
Cash paid during the year for interest-------4101112121211
Income Taxes Paid-----0125417114212198